Product
HRZE
Aliases
ethambutol, isoniazid, rifampicin
Name
Ethambutol
INN Name
Ethambutol hydrochloride
FDA Approved
Yes
7 clinical trials
1 organization
7 indications
1 document
Indication
Tuberculous MeningitisIndication
TuberculosisIndication
PulmonaryIndication
Multidrug-resistantIndication
Drug Sensitive TuberculosisClinical trial
A Phase 2 Study to Evaluate the Early Bactericidal Activity, Safety and Tolerability of Nebulised RESP301 in Adults With Newly Diagnosed, Rifampicin Susceptible Pulmonary TuberculosisStatus: Recruiting, Estimated PCD: 2024-04-30
Clinical trial
Comparative Evaluation of Intensified Short Course Regimen and Standard Regimen for Adults TB Meningitis : an Open-label Randomized Controlled TrialStatus: Not yet recruiting, Estimated PCD: 2027-09-01
Clinical trial
A Phase 2a, Dose Escalation, Controlled, Randomized Study to Evaluate Safety, Early Bactericidal Activity (EBA) and Pharmacokinetics of TBA-7371 in Adult Patients With Rifampicin-sensitive Pulmonary TuberculosisStatus: Completed, Estimated PCD: 2022-10-05
Clinical trial
A Phase 2b/c, Multi-Arm, 2-Stage, Duration Randomized Trial of the Efficacy and Safety of Two to Four Months Treatment With Regimens Containing Bedaquiline, OPC-167832, and Sutezolid, Plus Either Pretomanid or Delamanid, in Adults With Pulmonary TuberculosisStatus: Recruiting, Estimated PCD: 2027-10-01
Clinical trial
A Prospective Multicenter Phase II-study: Pharmacokinetics and Safety of High-Dose Rifampicin and Pyrazinamide in a Shorter Tuberculosis Treatment Compared With Standardized Treatment in Patients With Mild to Moderate Pulmonary TBStatus: , Estimated PCD: 2024-05-31
Clinical trial
An Open-Label, Partially Randomized Trial to Evaluate the Efficacy, Safety and Tolerability of a 4-month Treatment of Bedaquiline Plus Pretomanid Plus Moxifloxacin Plus Pyrazinamide (BPaMZ) Compared to a 6-month Treatment of HRZE/HR (Control) in Adult Participants With Drug-Sensitive Smear-Positive Pulmonary Tuberculosis (DS-TB) and a 6-month Treatment of BPaMZ in Adult Participants With Drug Resistant, Smear-Positive Pulmonary Tuberculosis (DR-TB)Status: Completed, Estimated PCD: 2021-07-01
Clinical trial
A Phase 2, Partially-blinded, Randomised Trial Assessing the Safety and Efficacy of TBAJ-876 or Bedaquiline, in Combination With Pretomanid and Linezolid in Adult Participants With Newly Diagnosed, Drug-sensitive, Smear-positive Pulmonary TuberculosisStatus: Recruiting, Estimated PCD: 2025-02-01
Document
DailyMed Label: EthambutolOrganization
Physicians Total Care, Inc.